How Mark Cuban Is Trying to Disrupt Big Pharma | WSJ
The Wall Street Journal The Wall Street Journal
5.18M subscribers
1,652,392 views
0

 Published On May 11, 2022

Mark Cuban’s drug company Cost Plus sells more than 200 generic medications, often at steep discounts to list prices. As drug prices remain out of reach for many Americans, Cuban is seeking to supply more affordable prescription drugs by removing insurance plans and healthcare industry middlemen, known as pharmacy benefit managers.

In an interview with WSJ, billionaire investor Mark Cuban explains how his low-cost, online drug company works and the challenges it faces in a consolidated industry run by big pharma.

0:00 Mark Cuban’s goal
1:11 Drug supply chain and PBMs
3:48 Cost Plus
5:41 What’s next?

#Healthcare #MarkCuban #WSJ

show more

Share/Embed